ISPOR Launches New HEOR Learning Platform

Jan 29, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced that it has launched its new online learning platform for HEOR education and training—ISPOR Education Center.

Value in Health Regional Issues Expands Editorial Scope and Reveals Plans to Transition to Gold Open Access Model

Jan 23, 2024

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Empowering Change: Transforming Health Systems in Low- and Middle-Income Countries

Jan 22, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.

ISPOR Publishes New Top 10 HEOR Trends Report

Jan 16, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced the publication of its “2024-2025 Top 10 HEOR Trends Report.” The Society publishes this report as part of its horizon scanning and monitoring of the trends that affect healthcare decision making around the world.

ISPOR Announces New Editor-in-Chief for Value in Health, Nancy J. Devlin, PhD

Dec 18, 2023

ISPOR announced the appointment of Nancy J. Devlin, PhD, University of Melbourne, Australia as an editor-in-chief for Value in Health.

Mitch Higashi, PhD Joins ISPOR as Associate Chief Science Officer

Dec 11, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that Mitch Higashi, PhD has joined the Society’s leadership team as Associate Chief Science Officer.

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

Medicare Could Save an Additional $10 Billion Annually Across 10 Drugs by Using a Therapeutic Reference Pricing Approach in Upcoming Price Negotiations

Nov 7, 2023

Value in Health announced the publication of a study showing that United States Medicare could save up to an additional $5-$10 billion dollars annually across 10 drugs if it negotiated prices using a therapeutic reference pricing approach rather than using the statutory ceiling price alone.

Global Medical Device Panel Finds Little Evidence Linking Health Technology Assessment Processes to Medical Device Purchasing Decisions

Nov 6, 2023

Value in Health, the official journal of ISPOR, announced the publication of the results of a systematic literature review showing that there is sparce evidence in the health research literature to link health technology assessment processes and outcomes with device purchasing decisions

ISPOR Announces 2023 Health Economics and Outcomes Research Award Honorees

Oct 3, 2023

ISPOR announced the recipients of its 2023 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×